Dandelion Root
Dandelion Root, licence 80000579: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- GNC Canada Holdings ULC
- NPN or DIN-HM
- 80000579
- Status
- Inactive licence
- Licence date
- 25 July 2005
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Taraxacum officinale Source : Racine | 500.0 mg | Not calculated |
Non-medicinal ingredients
Gélatine, cellulose, Stéarate de magnésium végétal, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 6.0 Capsule | 3.0 Tous les jours |
Uses authorised in Canada
Traditionally used to stimulate appetite and to increase bile flow.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are on diabetes medication, or if you are taking psychoactive medication.
- Précautions et mises en garde
Discontinue if hypersensitivity occurs such as contact dermatitis.
- Précautions et mises en garde
If symptoms persist consult a health care practitioner.
- Contre-indications
Do not use if you are pregnant or breastfeeding, if you are allergic to Asteraceae(daisy family) plants, if you have Gilbert's syndrome or Crigler-Najjar syndrome, if you have gall bladder inflammation, bile duct obstruction, or intestinal blockage, if you have bile duct cancer, pancreatic cancer, haemolytic anemia, intestinal spasm, liver cancer or liver disease.
Source
Official Health Canada record, licence 80000579
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.